Similar articles

• Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period.

  Hanberger H, Burman LG, Cars O, Erlandsson M, Gill H, Nilsson LE, Nordlinder D, Walther SM; ICU STRAMA Study Group. Hanberger H, et al. Acta Anaesthesiol Scand. 2007 Aug;51(7):937-41. doi: 10.1111/j.1399-6576.2007.01364.x. Acta Anaesthesiol Scand. 2007. PMID: 17635399
• [The pharmacodynamics and pharmacokinetics of fluoroquinolones in the evaluation of antibacterial therapy regimens].

  Smirnova LB, Sokolova VI. Smirnova LB, et al. Antibiot Khimioter. 2000;45(7):14-6. Antibiot Khimioter. 2000. PMID: 10987102 Russian.
• Comparison of in vitro susceptibilities to levofloxacin and ciprofloxacin with Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients in Northern Ireland.

  McKnight AJ, Shaw A, Goldsmith CE, Clarke L, Millar BC, McCaughan J, Elborn JS, Reid A, Moore JE. McKnight AJ, et al. Br J Biomed Sci. 2005;62(1):30-2. doi: 10.1080/09674845.2005.11978067. Br J Biomed Sci. 2005. PMID: 15816210 No abstract available.
• Potential mechanisms of resistance to the modern fluorinated 4-quinolones.

  Lewin CS, Allen RA, Amyes SG. Lewin CS, et al. J Med Microbiol. 1990 Mar;31(3):153-62. doi: 10.1099/00222615-31-3-153. J Med Microbiol. 1990. PMID: 2156074 Review. No abstract available.
• Surveillance of antibiotic resistance in European ICUs.

  Hanberger H, Diekema D, Fluit A, Jones R, Struelens M, Spencer R, Wolff M. Hanberger H, et al. J Hosp Infect. 2001 Jul;48(3):161-76. doi: 10.1053/jhin.2001.0987. J Hosp Infect. 2001. PMID: 11439002 Review.